07/28/2021 17:00
Clarín.com
Society
Updated 07/28/2021 17:07
While the controversy grows over the amount of vaccines that arrived in the country but have not yet been applied, the Government reported 15,883 new infections and
another 471 deaths
from coronavirus in Argentina
this Wednesday
.
The number of deaths marks a significant growth over the figures reported on Tuesday, when 249 fatalities were recorded.
With the figures reported this Wednesday, the country reached 4,891,810 infections and
104,822 deaths
from covid since the start of the pandemic.
The Ministry of Health reported that 257,729 people have the disease at this time.
Argentina remains the eighth nation with the highest number of covid infections since the start of the pandemic.
According to the ranking carried out by Johns Hopkins University, it is surpassed only by the United States, India, Brazil, Russia, France, the United Kingdom and Turkey.
In addition, it is one of the 11 countries that exceeded 100,000 deaths from coronavirus.
11 million vaccines not applied
The Public Vaccination Monitor this Wednesday throws a record that is data: there are
almost 6.5 million vaccines
that have been distributed in the provinces and await their application.
Added to this are 4.7 million vaccines not yet distributed by the national government.
In total, a stock of 11.2 million
.
41.8 million doses arrived in Argentina and 30.6 were applied.
At the end of June,
Clarín
had reported on this problem, when the vaccines in stock in the provinces, without applying, reached 4 million doses.
Now that number has grown 60%.
And 175% if one takes into account the amount that still remains in the power of the central administration, prior to its distribution.
This phenomenon occurs because 16 million vaccines arrived in July and the number of daily applications does not rise in proportion.
In some provinces they are having problems at this stage of the operation to get people to go to the vaccination centers.
Also art of the youngest population is the most reluctant to be immunized.
Trials in the City
With Moderna's vaccine available for children under 18 years of age with comorbidities, the next step that the Buenos Aires government will take in its immunization plan will be to add it to the vaccine combination study that seeks options to cover the deficit of component 2 of Sputnik V.
The current investigation began with applications on July 7.
That day, 180 people who were vaccinated with Sputnik V received doses of the second component from the same laboratory, and also from AstraZeneca and Sinopharm.
Last week, fifteen days after the puncture, they underwent blood extraction tests to assess whether they generated antibodies.
In that first period, no adverse effects were found among the 180 volunteers, according to official information.
Now, to add Moderna's vaccine to the study, the database will be used, which has more than 7,000 registered.
The methodology will be followed and another 60 people who received the first component of Sputnik V will have the application of Moderna's immunizer.
LM
Look also
The warning of the Ministry of Health: "There are still no cases of Delta without a travel history, but we will have them"
Record stock of vaccines: there are already 11 million doses against Covid without applying in the country